Azenta, Inc. (AZTA)
- Previous Close
51.50 - Open
51.68 - Bid 52.09 x 100
- Ask 52.26 x 100
- Day's Range
51.66 - 52.48 - 52 Week Range
36.01 - 69.16 - Volume
282,124 - Avg. Volume
453,169 - Market Cap (intraday)
2.91B - Beta (5Y Monthly) 1.49
- PE Ratio (TTM)
-- - EPS (TTM)
-0.32 - Earnings Date May 7, 2024 - May 13, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date Dec 2, 2021
- 1y Target Est
66.80
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions. This segment also provides sample management solutions, such as consumable vials and tubes, polymerase chain reaction, plates, instruments for supporting workflows, and informatics. The Life Sciences Services segment provides genomic services, that includes gene sequencing and gene synthesis services; and sample repository solutions, such as on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery and business continuity, and biospecimen procurement services, as well as project management and consulting services for genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development sectors. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.
www.azenta.com3,500
Full Time Employees
September 30
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: AZTA
Performance Overview: AZTA
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AZTA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AZTA
Valuation Measures
Market Cap
2.87B
Enterprise Value
1.95B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.00
Price/Book (mrq)
1.18
Enterprise Value/Revenue
3.05
Enterprise Value/EBITDA
33.99
Financial Highlights
Profitability and Income Statement
Profit Margin
-2.92%
Return on Assets (ttm)
-1.47%
Return on Equity (ttm)
-0.65%
Revenue (ttm)
641.02M
Net Income Avi to Common (ttm)
-17.37M
Diluted EPS (ttm)
-0.32
Balance Sheet and Cash Flow
Total Cash (mrq)
984.13M
Total Debt/Equity (mrq)
2.72%
Levered Free Cash Flow (ttm)
98.78M
Research Analysis: AZTA
Company Insights: AZTA
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: AZTA
AZTA: What does Argus have to say about AZTA?
AZENTA INC has an Investment Rating of HOLD; a target price of $55.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetAZTA: Lowering target price to $55.00
AZENTA INC has an Investment Rating of HOLD; a target price of $55.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetAZTA: Lowering target price to $61.00
AZENTA INC has an Investment Rating of HOLD; a target price of $61.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetAZTA: Raising target price to $62.00
AZENTA INC has an Investment Rating of HOLD; a target price of $62.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice Target